Parkinson's pill linked to gum changes – new study
NCT ID NCT07405268
First seen Feb 13, 2026 · Last updated May 22, 2026 · Updated 22 times
Summary
This study looks at whether the Parkinson's medication Levodopa-Benserazide affects gum health and inflammation. Researchers will compare gum measurements and saliva samples from 136 people, including those with and without Parkinson's and with or without gum disease. The goal is to understand the drug's impact on oral health, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIODONTAL DISEASES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Sağlık Bilimleri Üniversitesi Gülhane Diş Hekimliği Fakültesi
Ankara, 06010, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.